WHO Ebola Vaccine Agenda

http://www.who.int/immunization/diseases/ebola/Agenda_Consultation_Phase_2_Ebola_Vaccine_29-30_Sep.pdf?ua=1

Two candidate vaccines have clinical grade vials available for Phase 1 pre-licensure clinical trials.
These vaccines are
 cAd3-ZEBOV (GSK/NIAID)
 and
 rVS- ZEBOV (Newlink/PHAC).

V-